The Strategic Plan—the document which outlines how the HHS agencies are supposed to conduct autism research in the next few years—has been seriously delayed by repeated attempts to insert vaccine language.
The Plan is basically ready to be finalized. Months later than it should be because, well, people (read: Lyn Redwood) keep monopolizing the time for the meetings to discuss vaccines.
Would you like to see autism research move forward? Would you like to see the Combating Autism Act money actually appropriated and spent? Or, would you like to see future meetings continually monopolized by this one question?
If you are like me, you would like to see good research start. I’ve listed some of the initiatives that are stalled below. Good stuff. If you would like those projects to start sooner rather than later, send an email to Dr. Tom Insel, director of the NIMH and chair of the IACC. Let him know that it’s time for the IACC
Here are some points—
1) The Strategic Plan process has been significantly delayed by vaccine-oriented autism organizations
2) The proposed vaccine initiatives have not been checked by science subcommittees. I.e. they were inserted outside of the regular procedure.
3) Combatting Autism Act funded research has been stalled by the political maneuverings of the vaccine-oriented autism organizations.
4) It is time to put the CAA to work.
Here, I’ll make it easy for you: click here
Edit the email however it suits you. Hit send. Let the IACC know that CAA funded autism research should no longer be stalled by people pushing for vaccine research over all else.
Just in case you aren’t annoyed enough, here are some research initiatives that could be starting if the Plan were finalized rather than still in the tedious discussions by those who would rewrite it:
$5M on research for adults, seniors and adolescents:
Conduct at least two clinical trials to test the efficacy and cost-effectiveness of interventions, services and supports to optimize daily functioning for adolescents, adults, or seniors living with ASD by 2012. Estimated cost: $5,000,000 over 5 years.
Study quality of life for adults with ASD:
Launch at least two studies to assess and characterize variation and quality of life in adults living with ASD by 2011. Estimated cost: $1,500,000 over 3 years.
Randomized controlled trials—for both the very young and older kids. Yep, finally the RCT studies for
Conduct five randomized controlled trials of early intervention for infants and toddlers by 2011. Estimated cost: $15,000,000 over 5 years.
Launch three randomized controlled trials of interventions for school-aged and/or adolescents by 2012. Estimated cost: $14,000,000 over 5 years.
Genetic studies, anyone?
Identify genetic risk factors in at least 50% of people with ASD by 2014. Estimated cost: $30,000,000 over 6 years.
Coordinate and implement the inclusion of approximately 20,000 subjects for genome-wide association studies, as well as a sample of 1,200 for sequencing studies to examine more than 50 candidate genes by 2011. Estimated cost: $40,000,000 over 4 years.
And there is a lot more. A lot more including environmental factors, gene-environment interactions, biological markers—all stuff that is supposed to be near and dear to the hearts of the vaccine-orgs. One could understand them stalling the Plan if it was all genetics and adults and other subjects they find uninteresting, but the Plan is chock full of exactly what these orgs have been asking for.
Heck, I don’t see why their membership isn’t up in arms that these projects are being stalled. Just goes to show that the vaccines are really far and away the number one topic. Not surprising, but it is interesting to see them stall their “own” research projects for this one issue.
The Strategic Plan—the document which outlines how the HHS agencies are supposed to conduct autism research in the next few years—has been seriously delayed by repeated attempts to insert vaccine language.
The Plan is basically ready to be finalized. Months later than it should be because, well, people (read: Lyn Redwood) keep monopolizing the time for the meetings to discuss vaccines.
Would you like to see autism research move forward? Would you like to see the Combating Autism Act money actually appropriated and spent? Or, would you like to see future meetings continually monopolized by this one question?
If you are like me, you would like to see good research start. I’ve listed some of the initiatives that are stalled below. Good stuff. If you would like those projects to start sooner rather than later, send an email to Dr. Tom Insel, director of the NIMH and chair of the IACC. Let him know that it’s time for the IACC
Here are some points—
1) The Strategic Plan process has been significantly delayed by vaccine-oriented autism organizations
2) The proposed vaccine initiatives have not been checked by science subcommittees. I.e. they were inserted outside of the regular procedure.
3) Combatting Autism Act funded research has been stalled by the political maneuverings of the vaccine-oriented autism organizations.
4) It is time to put the CAA to work.
Here, I’ll make it easy for you: click here
Edit the email however it suits you. Hit send. Let the IACC know that CAA funded autism research should no longer be stalled by people pushing for vaccine research over all else.
Just in case you aren’t annoyed enough, here are some research initiatives that could be starting if the Plan were finalized rather than still in the tedious discussions by those who would rewrite it:
$5M on research for adults, seniors and adolescents:
Study quality of life for adults with ASD:
Randomized controlled trials—for both the very young and older kids. Yep, finally the RCT studies for
Genetic studies, anyone?
And there is a lot more. A lot more including environmental factors, gene-environment interactions, biological markers—all stuff that is supposed to be near and dear to the hearts of the vaccine-orgs. One could understand them stalling the Plan if it was all genetics and adults and other subjects they find uninteresting, but the Plan is chock full of exactly what these orgs have been asking for.
Heck, I don’t see why their membership isn’t up in arms that these projects are being stalled. Just goes to show that the vaccines are really far and away the number one topic. Not surprising, but it is interesting to see them stall their “own” research projects for this one issue.